Viatris Receives U.S. FDA Approval for RYZUMVI® for the Treatment of Presbyopia
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/22/2026
- Nasdaq futures sink as AI doubts resurface, oil jumps
- Oil jumps on escalating Middle East conflict
- Meta beats Q3 estimates, approves new nonvoting share class as AI spending surges
- Tesla stock up as automotive gross margin improves, free cash flow turns positive
- JPMorgan says AI stock selling may be nearing its limit as positioning resets
| (NASDAQ: VTRS) | Delayed: 18.45 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $18.45 | 52 Week High | $ | |||
| Open | $18.45 | 52 Week Low | $ | |||
| Day High | $18.45 | P/E | N/A | |||
| Day Low | $18.45 | EPS | $ | |||
| Volume | 463 | |||||
